Publication: SELNET clinical practice guidelines for soft tissue sarcoma and GIST.
No Thumbnail Available
Identifiers
Date
2021-11-13
Authors
Blay, J Y
Hindi, N
Bollard, J
Aguiar, S
Angel, M
Araya, B
Badilla, R
Bernabeu, D
Campos, F
Caro-Sanchez, C H S
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
Abstract
Soft tissue sarcoma (STS) is a heterogeneous group of neoplasms, encompassing >80 different histologic subtypes. Approximately three quarters of sarcomas arise from soft tissue, about 15% are gastrointestinal stromal tumours (GISTs), and bone sarcomas represent the remaining 10%. The current guidelines will focus on soft tissue and GIST, excluding Kaposi sarcoma and non-pleomorphic rhabdomyosarcoma.
Description
MeSH Terms
Gastrointestinal Stromal Tumors
Guidelines as Topic
Humans
Latin America
Sarcoma
Soft Tissue Neoplasms
Guidelines as Topic
Humans
Latin America
Sarcoma
Soft Tissue Neoplasms
DeCS Terms
Sarcoma de Kaposi
Rabdomiosarcoma
Neoplasias cutáneas
Tumores del estroma gastrointestinal
Neoplasias óseas
Sarcoma de Ewing
Rabdomiosarcoma
Neoplasias cutáneas
Tumores del estroma gastrointestinal
Neoplasias óseas
Sarcoma de Ewing
CIE Terms
Keywords
Sarcoma, Kaposi, Gastrointestinal Stromal Tumors, Sarcoma, Osteosarcoma, Bone Neoplasms, Rhabdomyosarcoma
Citation
Blay JY, Hindi N, Bollard J, Aguiar S Jr, Angel M, Araya B, et al. SELNET clinical practice guidelines for soft tissue sarcoma and GIST. Cancer Treat Rev. 2022 Jan;102:102312